Immunochemical features of a case of progressive rubella panencephalitis

J. S. Wolinsky, M. N. Waxham, Jay Hess, J. J. Townsend, J. R. Baringer

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Progressive rubella panencephalitis (PRP), a slowly progressive and fatal central nervous system (CNS) disorder due to rubella virus, is characterized by high cerebrospinal fluid (CSF) levels of immunoglobulins, oligoclonal bands and high CSF:serum rubella antibody titre ratios. Sera, CSF and neutral extracts of brain, spleen, lymph node and kidney obtained at autopsy from a case were analysed for immunoglobulin isotype and content by enzyme linked immunosorbent assays. Comparable titres of rubella specific IgA and IgG were found in sera and CSF, but accounted for a disproportionate amount of the isotype specific immunoglobulins of CSF (0.19%, 14.0%) as compared to serum (0.02%, 0.69%). The percentage of isotype specific immunoglobulins were not increased in extracts of most visceral tissues compared to serum, however, rubella specific IgA and IgG were disproportionately increased in extracts from most regions of brain sampled (1-60-fold and 8-27-fold respectively). No rubella specific IgM could be conclusively demonstrated in any specimen. Immunoprecipitation studies showed that the IgG reacted with the major glycoproteins (gp62, gp47-56 complex) and non-glycosylated polypeptide (p38) of radiolabelled rubella virions and infected cell lysates. These studies support the conclusion that a major portion of the rubella specific antibody is produced within the CNS of patients with PRP.

Original languageEnglish (US)
Pages (from-to)359-366
Number of pages8
JournalClinical and Experimental Immunology
Volume48
Issue number2
StatePublished - 1982
Externally publishedYes

Fingerprint

Rubella
Cerebrospinal Fluid
Immunoglobulin Isotypes
Serum
Immunoglobulin G
Immunoglobulin A
Oligoclonal Bands
Rubella virus
Central Nervous System Diseases
Brain
Immunoprecipitation
Virion
Immunoglobulin M
Immunoglobulins
Autopsy
Glycoproteins
Spleen
Central Nervous System
Lymph Nodes
Enzyme-Linked Immunosorbent Assay

ASJC Scopus subject areas

  • Immunology

Cite this

Wolinsky, J. S., Waxham, M. N., Hess, J., Townsend, J. J., & Baringer, J. R. (1982). Immunochemical features of a case of progressive rubella panencephalitis. Clinical and Experimental Immunology, 48(2), 359-366.

Immunochemical features of a case of progressive rubella panencephalitis. / Wolinsky, J. S.; Waxham, M. N.; Hess, Jay; Townsend, J. J.; Baringer, J. R.

In: Clinical and Experimental Immunology, Vol. 48, No. 2, 1982, p. 359-366.

Research output: Contribution to journalArticle

Wolinsky, JS, Waxham, MN, Hess, J, Townsend, JJ & Baringer, JR 1982, 'Immunochemical features of a case of progressive rubella panencephalitis', Clinical and Experimental Immunology, vol. 48, no. 2, pp. 359-366.
Wolinsky, J. S. ; Waxham, M. N. ; Hess, Jay ; Townsend, J. J. ; Baringer, J. R. / Immunochemical features of a case of progressive rubella panencephalitis. In: Clinical and Experimental Immunology. 1982 ; Vol. 48, No. 2. pp. 359-366.
@article{ca4a31f561f24aed9cc9a1b033154196,
title = "Immunochemical features of a case of progressive rubella panencephalitis",
abstract = "Progressive rubella panencephalitis (PRP), a slowly progressive and fatal central nervous system (CNS) disorder due to rubella virus, is characterized by high cerebrospinal fluid (CSF) levels of immunoglobulins, oligoclonal bands and high CSF:serum rubella antibody titre ratios. Sera, CSF and neutral extracts of brain, spleen, lymph node and kidney obtained at autopsy from a case were analysed for immunoglobulin isotype and content by enzyme linked immunosorbent assays. Comparable titres of rubella specific IgA and IgG were found in sera and CSF, but accounted for a disproportionate amount of the isotype specific immunoglobulins of CSF (0.19{\%}, 14.0{\%}) as compared to serum (0.02{\%}, 0.69{\%}). The percentage of isotype specific immunoglobulins were not increased in extracts of most visceral tissues compared to serum, however, rubella specific IgA and IgG were disproportionately increased in extracts from most regions of brain sampled (1-60-fold and 8-27-fold respectively). No rubella specific IgM could be conclusively demonstrated in any specimen. Immunoprecipitation studies showed that the IgG reacted with the major glycoproteins (gp62, gp47-56 complex) and non-glycosylated polypeptide (p38) of radiolabelled rubella virions and infected cell lysates. These studies support the conclusion that a major portion of the rubella specific antibody is produced within the CNS of patients with PRP.",
author = "Wolinsky, {J. S.} and Waxham, {M. N.} and Jay Hess and Townsend, {J. J.} and Baringer, {J. R.}",
year = "1982",
language = "English (US)",
volume = "48",
pages = "359--366",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Immunochemical features of a case of progressive rubella panencephalitis

AU - Wolinsky, J. S.

AU - Waxham, M. N.

AU - Hess, Jay

AU - Townsend, J. J.

AU - Baringer, J. R.

PY - 1982

Y1 - 1982

N2 - Progressive rubella panencephalitis (PRP), a slowly progressive and fatal central nervous system (CNS) disorder due to rubella virus, is characterized by high cerebrospinal fluid (CSF) levels of immunoglobulins, oligoclonal bands and high CSF:serum rubella antibody titre ratios. Sera, CSF and neutral extracts of brain, spleen, lymph node and kidney obtained at autopsy from a case were analysed for immunoglobulin isotype and content by enzyme linked immunosorbent assays. Comparable titres of rubella specific IgA and IgG were found in sera and CSF, but accounted for a disproportionate amount of the isotype specific immunoglobulins of CSF (0.19%, 14.0%) as compared to serum (0.02%, 0.69%). The percentage of isotype specific immunoglobulins were not increased in extracts of most visceral tissues compared to serum, however, rubella specific IgA and IgG were disproportionately increased in extracts from most regions of brain sampled (1-60-fold and 8-27-fold respectively). No rubella specific IgM could be conclusively demonstrated in any specimen. Immunoprecipitation studies showed that the IgG reacted with the major glycoproteins (gp62, gp47-56 complex) and non-glycosylated polypeptide (p38) of radiolabelled rubella virions and infected cell lysates. These studies support the conclusion that a major portion of the rubella specific antibody is produced within the CNS of patients with PRP.

AB - Progressive rubella panencephalitis (PRP), a slowly progressive and fatal central nervous system (CNS) disorder due to rubella virus, is characterized by high cerebrospinal fluid (CSF) levels of immunoglobulins, oligoclonal bands and high CSF:serum rubella antibody titre ratios. Sera, CSF and neutral extracts of brain, spleen, lymph node and kidney obtained at autopsy from a case were analysed for immunoglobulin isotype and content by enzyme linked immunosorbent assays. Comparable titres of rubella specific IgA and IgG were found in sera and CSF, but accounted for a disproportionate amount of the isotype specific immunoglobulins of CSF (0.19%, 14.0%) as compared to serum (0.02%, 0.69%). The percentage of isotype specific immunoglobulins were not increased in extracts of most visceral tissues compared to serum, however, rubella specific IgA and IgG were disproportionately increased in extracts from most regions of brain sampled (1-60-fold and 8-27-fold respectively). No rubella specific IgM could be conclusively demonstrated in any specimen. Immunoprecipitation studies showed that the IgG reacted with the major glycoproteins (gp62, gp47-56 complex) and non-glycosylated polypeptide (p38) of radiolabelled rubella virions and infected cell lysates. These studies support the conclusion that a major portion of the rubella specific antibody is produced within the CNS of patients with PRP.

UR - http://www.scopus.com/inward/record.url?scp=0020079860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020079860&partnerID=8YFLogxK

M3 - Article

VL - 48

SP - 359

EP - 366

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 2

ER -